{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:58:45Z","timestamp":1761170325593,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":119,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.hjc.2019.03.011","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T22:55:37Z","timestamp":1562021737000},"page":"114-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vitamin D: A cardiovascular risk biomarker or a treatment target?"],"prefix":"10.1016","volume":"60","author":[{"given":"Gerasimos","family":"Siasos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Theofilis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2019.03.011_bib1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2019.03.011_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10557-014-6562-5","article-title":"Oxidative stress and early atherosclerosis: novel antioxidant treatment","volume":"29","author":"Tousoulis","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hjc.2019.03.011_bib3","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2018.02.073","article-title":"Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis","volume":"71","author":"Siasos","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2019.03.011_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.hjc.2017.05.013","article-title":"Atherosclerosis and inflammation. Clinical aspects of a modern tale","volume":"58","author":"Synetos","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2019.03.011_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.hjc.2016.08.004","article-title":"Extent of coronary artery disease in patients undergoing angiography for stable or acute coronary syndromes","volume":"58","author":"Marini","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2019.03.011_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1573406411666150928111446","article-title":"Basic Mechanisms in Atherosclerosis: The Role of Calcium","volume":"12","author":"Kalampogias","year":"2016","journal-title":"Med Chem"},{"key":"10.1016\/j.hjc.2019.03.011_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.hjc.2018.06.014","article-title":"Vitamin D deficiency and cardiovascular disease: Fact or fiction?","volume":"59","author":"Tousoulis","year":"2018","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2019.03.011_bib8","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.2174\/1381612820666140619122937","article-title":"Vitamin D3, D2 and arterial wall properties in coronary artery disease","volume":"20","author":"Siasos","year":"2014","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.hjc.2019.03.011_bib9","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/j.ijcard.2013.06.151","article-title":"Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease","volume":"168","author":"Siasos","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hjc.2019.03.011_bib10","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.ijcard.2012.05.001","article-title":"Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease","volume":"167","author":"Tousoulis","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hjc.2019.03.011_bib11","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.hjc.2019.03.011_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-6686.2010.00171.x","article-title":"Clinical epidemiology of cardiovascular disease in chronic kidney disease","volume":"36","author":"Foley","year":"2010","journal-title":"J Ren Care"},{"key":"10.1016\/j.hjc.2019.03.011_bib13","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.jacc.2018.04.008","article-title":"Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease: Potential for Targeting Inflammation With Canakinumab","volume":"71","author":"Cherney","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2019.03.011_bib14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.114.03748","article-title":"Paricalcitol and endothelial function in chronic kidney disease trial","volume":"64","author":"Zoccali","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.hjc.2019.03.011_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00059-017-4605-y","article-title":"Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease : A meta-analysis","volume":"43","author":"Hu","year":"2018","journal-title":"Herz"},{"key":"10.1016\/j.hjc.2019.03.011_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ckj\/sfw145","article-title":"Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?","volume":"10","author":"Cianciolo","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.hjc.2019.03.011_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2008070692","article-title":"Vascular calcification: the killer of patients with chronic kidney disease","volume":"20","author":"Mizobuchi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.hjc.2019.03.011_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.hjc.2019.03.011_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","article-title":"Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis","volume":"7","author":"Cheng","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.hjc.2019.03.011_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2019.03.011_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.hjc.2019.03.011_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/15701611113119990028","article-title":"Clinical Uses of 1,25-dihydroxy-19-nor-vitamin D(2) (Paricalcitol)","volume":"12","author":"Bover","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.hjc.2019.03.011_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008776","article-title":"Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability","volume":"7","author":"Vila Cuenca","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2019.03.011_bib24","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.108.835223","article-title":"Molecular insights and therapeutic targets for diabetic endothelial dysfunction","volume":"120","author":"Xu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2019.03.011_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.117.09023","article-title":"Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients","volume":"70","author":"Sarafidis","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.hjc.2019.03.011_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2019.03.011_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000441364","article-title":"Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial","volume":"42","author":"Lundwall","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.hjc.2019.03.011_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jdiacomp.2015.01.004","article-title":"Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease","volume":"29","author":"Thethi","year":"2015","journal-title":"J Diabet Complicat"},{"key":"10.1016\/j.hjc.2019.03.011_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.hjc.2017.12.010","article-title":"Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism","volume":"60","author":"Giakoumis","year":"2019","journal-title":"Hellenic J Cardiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966619302301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966619302301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:12:39Z","timestamp":1761099159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966619302301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1109966619302301"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2019.03.011","relation":{},"ISSN":["1109-9666"],"issn-type":[{"type":"print","value":"1109-9666"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D: A cardiovascular risk biomarker or a treatment target?","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2019.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}